109 related articles for article (PubMed ID: 26222363)
1. Advances and new insights in the neuropathogenesis of dengue infection.
Puccioni-Sohler M; Rosadas C
Arq Neuropsiquiatr; 2015 Aug; 73(8):698-703. PubMed ID: 26222363
[TBL] [Abstract][Full Text] [Related]
2. Study of interleukin-6 and interleukin-8 levels in patients with neurological manifestations of dengue.
Mehta VK; Verma R; Garg RK; Malhotra HS; Sharma PK; Jain A
J Postgrad Med; 2017; 63(1):11-15. PubMed ID: 28079042
[TBL] [Abstract][Full Text] [Related]
3. Neurological Manifestations of Dengue Infection.
Li GH; Ning ZJ; Liu YM; Li XH
Front Cell Infect Microbiol; 2017; 7():449. PubMed ID: 29119088
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of interferon stimulated genes in central nervous system of mice infected with dengue virus Type-1.
Bordignon J; Probst CM; Mosimann AL; Pavoni DP; Stella V; Buck GA; Satproedprai N; Fawcett P; Zanata SM; de Noronha L; Krieger MA; Duarte Dos Santos CN
Virology; 2008 Aug; 377(2):319-29. PubMed ID: 18570970
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the central nervous system in patients with dengue virus infection.
Domingues RB; Kuster GW; Onuki-Castro FL; Souza VA; Levi JE; Pannuti CS
J Neurol Sci; 2008 Apr; 267(1-2):36-40. PubMed ID: 17959198
[TBL] [Abstract][Full Text] [Related]
6. DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
Thisyakorn U; Thisyakorn C
Southeast Asian J Trop Med Public Health; 2015; 46 Suppl 1():118-22. PubMed ID: 26506737
[TBL] [Abstract][Full Text] [Related]
7. Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvement.
Hapuarachchi HC; Oh HM; Thein TL; Pok KY; Lai YL; Tan LK; Lee KS; Leo YS; Ng LC
J Clin Virol; 2013 May; 57(1):91-4. PubMed ID: 23415634
[TBL] [Abstract][Full Text] [Related]
8. Unique neurological manifestations of dengue virus in pediatric population: a case series.
Samanta M; Kundu CK; Guha G; Chatterjee S
J Trop Pediatr; 2012 Oct; 58(5):398-401. PubMed ID: 22241072
[TBL] [Abstract][Full Text] [Related]
9. Dengue neurovirulence in mice: identification of molecular signatures in the E and NS3 helicase domains.
Bordignon J; Strottmann DM; Mosimann AL; Probst CM; Stella V; Noronha L; Zanata SM; Dos Santos CN
J Med Virol; 2007 Oct; 79(10):1506-17. PubMed ID: 17705192
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in dengue virus pathology.
Vervaeke P; Vermeire K; Liekens S
Rev Med Virol; 2015 Jan; 25(1):50-67. PubMed ID: 25430853
[TBL] [Abstract][Full Text] [Related]
11. Neurological complication of dengue infection.
Murthy JM
Neurol India; 2010; 58(4):581-4. PubMed ID: 20739796
[TBL] [Abstract][Full Text] [Related]
12. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis.
Soares CN; Faria LC; Peralta JM; de Freitas MR; Puccioni-Sohler M
J Neurol Sci; 2006 Nov; 249(1):19-24. PubMed ID: 16870213
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area.
Araújo FM; Araújo MS; Nogueira RM; Brilhante RS; Oliveira DN; Rocha MF; Cordeiro RA; Araújo RM; Sidrim JJ
Neurology; 2012 Mar; 78(10):736-42. PubMed ID: 22357720
[TBL] [Abstract][Full Text] [Related]
14. Callithrix penicillata: a feasible experimental model for dengue virus infection.
Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
[TBL] [Abstract][Full Text] [Related]
15. BALB/c mice infected with DENV-2 strain 66985 by the intravenous route display injury in the central nervous system.
Salomão NG; Rabelo K; Póvoa TF; Alves AMB; da Costa SM; Gonçalves AJS; Amorim JF; Azevedo AS; Nunes PCG; Basílio-de-Oliveira CA; Basílio-de-Oliveira RP; Geraldo LHM; Fonseca CG; Lima FRS; Mohana-Borges R; Silva EM; Dos Santos FB; Oliveira ERA; Paes MV
Sci Rep; 2018 Jun; 8(1):9754. PubMed ID: 29950590
[TBL] [Abstract][Full Text] [Related]
16. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
[TBL] [Abstract][Full Text] [Related]
17. Meningitis determined by oligosymptomatic dengue virus type 3 infection: report of a case.
Soares CN; Cabral-Castro MJ; Peralta JM; Freitas MR; Puccioni-Sohler M
Int J Infect Dis; 2010 Feb; 14(2):e150-2. PubMed ID: 19501535
[TBL] [Abstract][Full Text] [Related]
18. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations of dengue virus infection.
Misra UK; Kalita J; Syam UK; Dhole TN
J Neurol Sci; 2006 May; 244(1-2):117-22. PubMed ID: 16524594
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
Kyle JL; Beatty PR; Harris E
J Infect Dis; 2007 Jun; 195(12):1808-17. PubMed ID: 17492597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
